A Virus‐Spike Tumor‐Activatable Pyroptotic Agent
- 1 February 2021
- Vol. 17 (8), 2006599
- https://doi.org/10.1002/smll.202006599
Abstract
Invoking the occurrence of pyroptosis is an emerging strategy for the treatment of cancer. However, the practical applications of pyroptosis for cancer therapy are currently hindered due to the lack of tumor‐specific and efficient pyroptotic agents in vivo. Herein, a virus‐spike tumor‐activatable pyroptotic agent (VTPA) for cancer‐specific therapy is reported. The VTPA is composed of an organosilica coated iron oxide nanoparticle core and spiky manganese dioxide protrusions, which can readily accumulate in tumor after systemic administration, facilitate the tumor intracellular lysosomal rupture, and be degraded by tumor over‐expressed intracellular glutathione (GSH) to release Mn ions and iron oxide nanoparticles (IONPs) for the synergetic activation of nucleotide binding oligomerization domain‐like receptors protein 3 (NLRP3) inflammasomes. Consequently, the activation of NLRP3 inflammasomes and the release of lactate dehydrogenase of tumor cells are observed after the treatment of VTPA, resulting in a specific pyroptotic cell death. To our best knowledge, the structure‐dependent and tumor intracellular GSH activatable pyroptotic agents represent the first demonstration of cancer‐specific pyroptosis in vivo, providing a novel paradigm for the development of next‐generation cancer‐specific pyroptotic nanomedicine.Funding Information
- National Basic Research Program of China (2016YFA0203600)
- National Natural Science Foundation of China (31822019, 32071374, 51703195, 91859116)
- Natural Science Foundation of Zhejiang Province (LGF19C100002)
- Fundamental Research Funds for the Central Universities (2018QNA7020, 2019XZZX004‐15)
- National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology (2018ZX09711002)
This publication has 49 references indexed in Scilit:
- Break‐up of Two‐Dimensional MnO2 Nanosheets Promotes Ultrasensitive pH‐Triggered Theranostics of CancerAdvanced Materials, 2014
- A general mechanism for intracellular toxicity of metal-containing nanoparticlesNanoscale, 2014
- Drug Delivery with PEGylated MoS2 Nano‐sheets for Combined Photothermal and Chemotherapy of CancerAdvanced Materials, 2014
- Toxicity of inorganic nanomaterials in biomedical imagingBiotechnology Advances, 2014
- Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell deathCell Cycle, 2013
- Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T2 contrast agent with tunable proton relaxivitiesContrast Media & Molecular Imaging, 2012
- Novel metal-based anticancer drugs: a new challenge in drug deliveryCurrent Opinion in Pharmacology, 2012
- NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?Nature Reviews Immunology, 2010
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Multifunctional Uniform Nanoparticles Composed of a Magnetite Nanocrystal Core and a Mesoporous Silica Shell for Magnetic Resonance and Fluorescence Imaging and for Drug DeliveryAngewandte Chemie, 2008